
Over the last 7 days, the Life Sciences industry has dropped 2.2%, driven by declines in HeXun Biosciences and EirGenix of 10.0% and 1.4%, respectively. However, the industry is down 7.5% over the past year.
Has the Taiwanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 02 Jan 2026 | NT$33.9b | NT$2.4b | -NT$689,929,000.00 | 25.8x | -49.2x | 14x |
| Sun, 30 Nov 2025 | NT$37.9b | NT$2.4b | -NT$670,921,000.00 | 19.9x | -56.5x | 15.5x |
| Tue, 28 Oct 2025 | NT$36.3b | NT$2.5b | -NT$870,437,000.00 | 18.5x | -41.7x | 14.8x |
| Thu, 25 Sep 2025 | NT$35.3b | NT$2.5b | -NT$870,437,000.00 | 19.8x | -40.5x | 14.4x |
| Sat, 23 Aug 2025 | NT$35.6b | NT$2.5b | -NT$819,216,000.00 | 20.6x | -43.5x | 14.5x |
| Mon, 21 Jul 2025 | NT$34.4b | NT$2.5b | -NT$600,003,000.00 | 22.3x | -57.4x | 14x |
| Wed, 18 Jun 2025 | NT$32.9b | NT$2.5b | -NT$600,003,000.00 | 23.5x | -54.9x | 13.4x |
| Fri, 16 May 2025 | NT$31.8b | NT$2.5b | -NT$604,301,000.00 | 23.3x | -52.6x | 13x |
| Sun, 13 Apr 2025 | NT$30.7b | NT$2.5b | -NT$540,128,000.00 | 23.4x | -56.9x | 12.5x |
| Tue, 11 Mar 2025 | NT$36.3b | NT$2.6b | -NT$854,432,000.00 | 24.6x | -42.5x | 14.2x |
| Thu, 06 Feb 2025 | NT$37.2b | NT$2.6b | -NT$854,432,000.00 | 24x | -43.5x | 14.5x |
| Sat, 04 Jan 2025 | NT$34.5b | NT$2.6b | -NT$854,432,000.00 | 22.8x | -40.4x | 13.5x |
| Mon, 02 Dec 2024 | NT$42.2b | NT$2.6b | -NT$854,432,000.00 | 23.7x | -49.4x | 16.5x |
| Wed, 30 Oct 2024 | NT$42.1b | NT$2.5b | -NT$712,402,000.00 | 24.5x | -59x | 16.7x |
| Fri, 27 Sep 2024 | NT$41.2b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -49.3x | 18.1x |
| Sun, 25 Aug 2024 | NT$40.9b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -48.9x | 18x |
| Tue, 23 Jul 2024 | NT$42.7b | NT$2.1b | -NT$797,765,000.00 | 33.2x | -53.5x | 20x |
| Thu, 20 Jun 2024 | NT$41.5b | NT$2.1b | -NT$797,765,000.00 | 34.3x | -52x | 19.4x |
| Sat, 18 May 2024 | NT$40.7b | NT$2.1b | -NT$893,893,000.00 | 32.1x | -45.6x | 19.1x |
| Mon, 15 Apr 2024 | NT$40.9b | NT$2.1b | -NT$903,875,000.00 | 30.9x | -45.3x | 19.4x |
| Wed, 13 Mar 2024 | NT$40.5b | NT$2.1b | -NT$611,249,000.00 | 32.8x | -66.3x | 19.7x |
| Fri, 09 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
| Sun, 07 Jan 2024 | NT$46.5b | NT$2.1b | -NT$610,218,000.00 | 34.4x | -76.3x | 22.4x |
| Tue, 05 Dec 2023 | NT$49.7b | NT$2.1b | -NT$610,218,000.00 | 34.9x | -81.4x | 23.9x |
| Thu, 02 Nov 2023 | NT$49.0b | NT$2.2b | -NT$497,769,000.00 | 31.6x | -98.5x | 22x |
| Sat, 30 Sep 2023 | NT$48.0b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -96.4x | 21.6x |
| Mon, 28 Aug 2023 | NT$43.1b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -86.7x | 19.4x |
| Wed, 26 Jul 2023 | NT$49.0b | NT$2.5b | -NT$274,767,000.00 | 42.3x | -178.2x | 20x |
| Fri, 23 Jun 2023 | NT$48.4b | NT$2.5b | -NT$274,767,000.00 | 43.2x | -176.1x | 19.7x |
| Sun, 21 May 2023 | NT$50.1b | NT$2.6b | -NT$38,534,000.00 | 41.9x | -1299x | 19.1x |
| Tue, 18 Apr 2023 | NT$50.6b | NT$2.7b | -NT$29,761,000.00 | 24.7x | -1700.3x | 19x |
| Thu, 16 Mar 2023 | NT$48.2b | NT$2.7b | NT$82.4m | 24x | 585.8x | 18.2x |
| Sat, 11 Feb 2023 | NT$52.8b | NT$2.7b | NT$85.3m | 19.8x | 619x | 19.7x |
| Mon, 09 Jan 2023 | NT$47.8b | NT$2.7b | NT$85.3m | 18.6x | 560.2x | 17.9x |
560.2x
Which industries have driven the changes within the Taiwanese Healthcare industry?
| TW Market | 2.14% | |
| Healthcare | -0.93% | |
| Life Sciences | -2.20% | |
| Clinical Research and Equipment | -2.20% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6939 TFBS Bioscience | NT$21.40 | 4.4% +NT$31.4m | -24.1% | n/a |